Document Detail


Use of bioabsorbable staple reinforcement material in gastric bypass: a prospective randomized clinical trial.
MedLine Citation:
PMID:  17567538     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Staple line failure, although uncommon, can result in significant morbidity and, even, mortality. Staple line buttressing has been developed to improve staple line strength, decrease bleeding, and minimize the risk of leak. Many different products are currently available. However, most have not been proved in clinical trials for their clinical relevance. METHODS: From April 2004 to March 2005, 48 morbidly obese patients who had undergone laparoscopic Roux-en-Y gastric bypass were enrolled in this study. The patients were randomly allocated to 2 groups according to whether polyglycolide acid and trimethylene carbonate (Seamguard) was (group 1, n = 24) or was not (group 2, n = 24) used in an investigator-initiated study. All patients underwent barium radiography at 3 and 12 months postoperatively. RESULTS: Peri- and postoperative mortality were absent. The intraoperative methylene blue test was positive in 1 patient in group 2. No conversion to laparotomy was needed. No patient required reoperation or transfusion for extraluminal bleeding, and no anastomotic leaks were detected in either group postoperatively. The mean number of clip instruments used was significantly lower in group 1 patients (2 versus 22, P <.0001, odds ratio 121.0, 95% confidence interval 12.5-1491). The operative time was significantly less in group 1 (115 +/- 30.0 min, range 85-210) compared with that in group 2 (150 +/- 51.7 min, range 90-240; P <.05). The postoperative hemoglobin level was significantly greater in group 1 (12.47 +/- 1.7 mg/dL, range 9.2-14.8) compared with that in group 2 (11.1 +/- 1.9 mg/dL, range 8.1-14.6; P <.05). Gastrogastric fistula formation was detected in 3 patients (12.5%) in group 2, with no statistically significant difference (P = .2). CONCLUSION: The results of our study have shown that synthetic reinforcement material minimizes staple line bleeding and reduces the operative time, with no animal source contamination. No adverse events related to the resorbable buttressing material were observed.
Authors:
Karl A Miller; Antonia Pump
Related Documents :
23686558 - The evaluation of spontaneous space closure after the extraction of first permanent mol...
7032328 - Modification of the gastric partitioning operation for morbid obesity.
16079698 - Delay of transverse rectus abdominis myocutaneous flap reconstruction improves flap rel...
10852518 - Morbidly obese patients with severe obstructive sleep apnea: is airway reconstructive s...
11103028 - De novo stenting of descending thoracic aorta in takayasu arteritis: intermediate-term ...
17159658 - Early virologic rebound in a pilot trial of ritonavir-boosted atazanavir as maintenance...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2007-06-12
Journal Detail:
Title:  Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery     Volume:  3     ISSN:  1550-7289     ISO Abbreviation:  -     Publication Date:    2007 Jul-Aug
Date Detail:
Created Date:  2007-07-30     Completed Date:  2007-10-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101233161     Medline TA:  Surg Obes Relat Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  417-21; discussion 422     Citation Subset:  IM    
Affiliation:
Obesity Surgery Center, Hallein Clinic, Hallein, Austria. karl.miller@kh-hallein.at
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Absorbable Implants*
Adult
Anastomosis, Roux-en-Y
Blood Loss, Surgical / prevention & control
Chi-Square Distribution
Dioxanes
Female
Gastric Bypass / methods*
Gastroscopy
Hemostasis, Surgical / methods*
Humans
Male
Middle Aged
Obesity, Morbid / surgery*
Polyglycolic Acid
Prospective Studies
Statistics, Nonparametric
Surgical Stapling / methods*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Dioxanes; 0/trimethylene carbonate; 26009-03-0/Polyglycolic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Application of a biomarker battery for the evaluation of the sublethal effects of pollutants in the ...
Next Document:  Selective, versus routine, upper gastrointestinal series leads to equal morbidity and reduced hospit...